Wells Fargo analyst Michael Turrin raised the firm’s price target on DocuSign (DOCU) to $67 from $65 and keeps an Underweight rating on the shares. The firm notes the company’s Q1 showed a bit of mean reversion after a few quarters of improving growth, with billings +4% and FY26 CC billings outlook lower. Key debate going forward is tied to emerging IAM product story and potential uplift, Wells says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign’s Strategic Shift and Macroeconomic Challenges Lead to Hold Rating
- DocuSign: Strong Fundamentals and Growing IAM Demand Justify Buy Rating Despite Billing Challenges
- Docusign Reports Strong Q1 Fiscal 2026 Results
- Closing Bell Movers: Lululemon falls over 20% on soft guidance
- DocuSign down 14% to $79.52 after Q1 results, FY26 guidance